Antimicrobial therapies for prevention of recurrent acute exacerbations of COPD (AECOPD): beyond the guidelines
M Brennan, MJ McDonnell, MJ Harrison… - Respiratory …, 2022 - Springer
Background Unfortunately, many COPD patients continue to exacerbate despite good
adherence to GOLD Class D recommended therapy. Acute exacerbations lead to an …
adherence to GOLD Class D recommended therapy. Acute exacerbations lead to an …
COPD exacerbations· 2: aetiology
E Sapey, RA Stockley - Thorax, 2006 - thorax.bmj.com
Exacerbations of COPD are thought to be caused by complex interactions between the host,
bacteria, viruses, and environmental pollution. These factors increase the inflammatory …
bacteria, viruses, and environmental pollution. These factors increase the inflammatory …
Antimicrobial peptides in COPD-basic biology and therapeutic applications
R Bals, PS Hiemstra - Current drug targets, 2006 - ingentaconnect.com
A large number of studies have implicated activation of innate immune mechanisms in the
pathogenesis of chronic obstructive pulmonary disease (COPD). Accumulation of …
pathogenesis of chronic obstructive pulmonary disease (COPD). Accumulation of …
COPD: is there light at the end of the tunnel?
PJ Barnes - Current opinion in pharmacology, 2004 - Elsevier
No currently available treatments reduce the progression or suppress the inflammation of
chronic obstructive pulmonary disease (COPD). However, with a better understanding of the …
chronic obstructive pulmonary disease (COPD). However, with a better understanding of the …
Risk factors of chronic obstructive pulmonary disease exacerbations
SP Hogea, E Tudorache, AP Fildan… - The clinical …, 2020 - Wiley Online Library
Abstract Chronic Obstructive Pulmonary Disease (COPD) is a chronic respiratory disease
characterised by persistent respiratory symptoms and airflow limitation. COPD has a major …
characterised by persistent respiratory symptoms and airflow limitation. COPD has a major …
Biomarkers that predict and guide therapy for exacerbations of chronic obstructive pulmonary disease
CE Brightling - Annals of the American Thoracic Society, 2013 - atsjournals.org
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease. COPD
exacerbations have a major impact on morbidity and mortality. The etiology of COPD …
exacerbations have a major impact on morbidity and mortality. The etiology of COPD …
Respiratory viral and bacterial exacerbations of COPD—the role of the airway epithelium
ME Love, D Proud - Cells, 2022 - mdpi.com
COPD is a leading cause of death worldwide, with acute exacerbations being a major
contributor to disease morbidity and mortality. Indeed, exacerbations are associated with …
contributor to disease morbidity and mortality. Indeed, exacerbations are associated with …
New drugs for exacerbations of chronic obstructive pulmonary disease
TT Hansel, PJ Barnes - The Lancet, 2009 - thelancet.com
Tobacco smoking is the dominant risk factor for chronic obstructive pulmonary disease
(COPD), but viral and bacterial infections are the major causes of exacerbations in later …
(COPD), but viral and bacterial infections are the major causes of exacerbations in later …
Pharmacotherapeutic approaches to preventing acute exacerbations of chronic obstructive pulmonary disease
MLK Han, FJ Martinez - Proceedings of the American Thoracic …, 2011 - atsjournals.org
The significance of acute exacerbations in chronic obstructive pulmonary disease
(AECOPDs) is increasingly appreciated. AECOPDs result in significant morbidity and …
(AECOPDs) is increasingly appreciated. AECOPDs result in significant morbidity and …
Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits
AG Mathioudakis, W Janssens, P Sivapalan… - Thorax, 2020 - thorax.bmj.com
Acute exacerbations of chronic obstructive pulmonary disease (COPD) are associated with a
significant mortality, health and economic burden. Their diagnosis, assessment and …
significant mortality, health and economic burden. Their diagnosis, assessment and …